UK To Offer Firms More Flexible Commercial Deals On ‘Transformative’ Drugs, Earlier Access To Market

 
• By Ian Schofield
Access
Half a dozen products a year will gain early acces to market under UK government plans

More from Drug Pricing

More from Scrip